Sensitivity and specificity of OraScan® toluidine blue mouthrinse in the detection of oral cancer and precancer

Journal of Oral Pathology and Medicine

Volumn 25, Issue 3, 1996, Pages 97-103

  Warnakulasuriya, K A A S ^a   Johnson, Newell W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer detection; Oral cancer; Orascan; Precancer, oral; Screening; Sensitivity; Specificity; Toluidine blue

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT; TOLONIUM CHLORIDE;

ANALYTICAL EQUIPMENT; ARTICLE; ASIA; CANCER INVASION; CARCINOMA; EPITHELIUM; ERYTHROPLASIA; ETHNOLOGY; FEMALE; HEALTH SURVEY; HUMAN; LABORATORY DIAGNOSIS; LEUKOPLAKIA; LICHEN PLANUS; MALE; MIDDLE AGED; MOUTH DISEASE; MOUTH HYGIENE; MOUTH MUCOSA; MOUTH TUMOR; MOUTH ULCER; PATHOLOGY; PRECANCER; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM;

ASIA; CARCINOMA; COLORING AGENTS; EPITHELIUM; ERYTHROPLASIA; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; LICHEN PLANUS, ORAL; LONDON; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; MOUTHWASHES; NEOPLASM INVASIVENESS; ORAL SUBMUCOUS FIBROSIS; ORAL ULCER; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS; REAGENT KITS, DIAGNOSTIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOLONIUM CHLORIDE;

EID: 0030090501     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1996.tb00201.x     Document Type: Article

References (31)

1. STRONG MS, VAUGHAN CW, INCZE JA. Toluidine blue in the management of carcinoma of the oral cavity. Arch Otolaryngol 1968; 87: 527-31.
2. SHEDD DP, HUKILL PB, BAHN S. In vivo staining properties of oral cancer. Am J Surg 1965; 110: 631-4.
3. NIEBEL HH, CHOMET B. In vivo staining test for delineation of oral intraepithelial neoplastic change: preliminary report. J Am Dent Assoc 1964; 68: 801-6.
4. SHEDD DP, HUKILL PB, BAHN S, FERRARO RH. Further appraisal of in vivo staining properties of oral cancer. Arch Surg 1967; 95: 16-22.
5. MYERS EN. The toluidine blue test in lesions of the oral cavity. Ca 1970; 20: 135-7.
6. SRIVASTAVA YC, MATHUR MN. Toluidine blue staining test for early detection of oral cancer. J Indian Dent Assoc 1971; 43: 98-101.
7. ROSEN IB, CORNISH M, EDELSON J. Detection of early oral cancer by Toluidine blue. J Can Dent Assoc 1971; 37: 347-9.
8. VAHIDY NA, ZAIDI SHM, JAFAREY NA. Toluidine blue test for detection of carcinoma of the oral cavity: evaluation. J Surg Oncol 1972; 4: 434-8.
9. REDDY CRRM, RAMULU C, SUNDARESHWAR B, RAJU MVS, GOPAL R, SARMA R. Toluidine blue staining of oral cancer and precancerous lesions. Indian J Med Res 1973; 61: 1161-4.
10. SIGURDSON A, WILLEN R. In vivo fargning med Toluidine blue som hjalpmedel for lokalisation av provexcisionstalle vid misstankt skivepitelcancer i munhalan. Swed Dent J 1975; 68: 117-26.
11. BARRELLIER P, RAME J-P, CHASLE J, SOUQUIERES Y, LECACHEUX B. Le depistage des cancers de la cavite buccale par le bleu de toluidine. Actualities Odonto-Stomatol 1932; 137: 87-92.
12. SILVERMAN S JR, MIGLIORATI C, BARBOSA J. Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg Oral Med Oral Pathol 1984; 57: 379-82.
13. EPSTEIN JB, SCULLY C, SPINELLI JJ. Toluidine blue and Lugol's iodine application in the assessment of oral malignant diasease and lesions at risk of malignancy. J Oral Pathol Med 1992; 22: 160-3.
14. PIZER ME, DUBOIS DD. An assessment of Toluidine blue for the diagnosis of lip lesions. Virginia Med 1979; 106: 860-2.
15. MASHBERG A. Reevaluation of Toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: continuing prospective study of oral cancer. III. Cancer 1980; 46: 758-63.
16. MASHBERG A. Tolonium (toluidine blue) rinse - a screening method for recognition of squamous carcinoma. JAMA 1981; 245: 2408-10.
17. MASHBERG A. Final evaluation of tolonium chloride rinse for screening of high-risk patients with asymptomatic squamous carcinoma. J Am Dent Assoc 1983; 106: 319-23.
18. MOYER GN, TAYBOS GM, PELLEU GB. Toluidine blue rinse: potential for benign lesions in early detection of oral neoplasms. J Oral Med 1986; 41: 111-3.
19. RICHART RM. A clinical staining test for the in vivo delineation of dysplasia and carcinoma in situ. Am J Obstet Gynecol 1963; 86: 703-12.
20. POSWILLO D. Evaluation, surveillance and treatment of panoral leukoplakia. J Maxillofac Surg 1975; 3: 205-11.
21. ROSENBERG D, CRETIN S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol 1989; 67: 621-7.
22. Editorial. Clinical stains for cancer. Lancet 1982; 1: 320-4.
23. MENNIGMANN HD, MULLER W. Dependence of the mutagenic power of heteroatomic dyes on their DNA-base-pair specificity. Mutat Res 1981; 91: 183-91.
24. FERGUSON LR, BAGULEY BC. Verapamil as a co-mutagen in the Salmonella/mammalian microsome mutagenicity test. Mut Res 1988; 209: 56-62.
25. DUNIPACE AJ, BEAVEN R, NOBLITT T, LI Y, ZUNT S, STOOKEY G. Mutagenic potential of toluidine blue evaluated in the Ames test. Mut Res 1992; 279: 255-9.
26. REDMAN RS, KRASNOW SH, SNIFFEN RA. Evaluation of the carcinogenic potential of toluidine blue O in the hamster cheek pouch. Oral Surg Oral Med Oral Pathol 1992; 74: 473-80.
27. SILVERMAN S. Early diagnosis of oral cancer. Cancer 1988; 62: 1796-9.
28. WORLD HEALTH ORGANIZATION. Guide to epidemiology and diagnosis of oral mucosal diaseases and conditions. Community Dent Oral Epidemiol 1980; 8: 1-26.
29. SMITH CJ, PINDBORG JJ. Histological grading of oral epithelial atypia by the use of photographical standards. Copenhagen: C Hamburgers Bogtrykkeri, 1969.
30. WARNAKULASURIYA KAAS. Clinical and pathological criteria for diagnosis of oral submucous fibrosis. In: Proceedings of the 1st Asia-Pacific workshop for oral mucosal lesions. Nagoya, Japan: Nagoya University Press, 1992.
31. WARNAKULASURIVA S, EKANAYAKE A, STJERNSWARD J, PINDBORG JJ. Compliance following referral in the early detection of oral cancer and precancer in Sri Lanka. Community Dent Oral Epidemiol 1988; 16: 326-9.